Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

iShares Biotechnology ETF (IBB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
128.68 -1.97    -1.51%
21/01 - Closed. Currency in USD ( Disclaimer )
After Hours
128.20
-0.48
-0.37%
18:40:03 - Real-time Data
Type:  ETF
Market:  United States
Issuer:  iShares
ISIN:  US4642875565 
CUSIP:  464287556
Underlying:  NQ Biotechnology
  • Volume: 4,331,608
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 128.20 - 131.50
iShares Nasdaq Biotechnology 128.68 -1.97 -1.51%
Jefferies bearish on biotechs, sees 6% near-term downside
Jefferies bearish on biotechs, sees 6% near-term downside By Seeking Alpha - Jan 23, 2019

Jefferies healthcare strategist Jared Holtz is a short-term biotech bear saying that profit-taking "makes sense" through this earnings season considering the sector's market-leading performance so far...

Hospitals squeezed by high drug costs
Hospitals squeezed by high drug costs By Seeking Alpha - Jan 16, 2019

A study funded by the American Hospital Association, Federation of American Hospitals and the American Society of Health-System Pharmacists found that total drug spend per hospital admission rose...

FDA to beef up cell and gene therapy staff
FDA to beef up cell and gene therapy staff By Seeking Alpha - Jan 15, 2019

Citing the 800 active INDs for cell therapy and gene therapy candidates and the expectation that it will be receiving more that 200 INDs each year by 2020, FDA Commission Scott Gottlieb, M.D.,...

U.S. government shutdown hampers FDA
U.S. government shutdown hampers FDA By Seeking Alpha - Jan 02, 2019

FDA Commissioner Scott Gottlieb, M.D. says the U.S. government shutdown prevents the agency from accepting new product applications under user fee programs (PDUFA, GDUFA, BsUFA, MDUFA, ADUFA, AGDUFA)...

Biotechs could face cash crunch next year - Leerink
Biotechs could face cash crunch next year - Leerink By Seeking Alpha - Nov 28, 2018

Endpoints News' John Carroll reports that, according to Leerink's Geoffrey Porges, a number of biotechs may encounter a need for additional capital next year. According to Leerink's estimate, biotech...

Builders and banks lead sector drawdowns
Builders and banks lead sector drawdowns By Seeking Alpha - Oct 27, 2018

via Lawrence McDonaldFrom "recent" highs ...Builders (NYSEARCA:XHB) -23.5%Regional banks (NYSEARCA:KRE) -23.2%Biotechs (NASDAQ:IBB) -17.5%Energy (NYSEARCA:XLE) -16.5%Russell 2000 (NYSEARCA:IWM)...

President promises lower drug prices
President promises lower drug prices By Seeking Alpha - Oct 25, 2018 1

Speaking at the Department of Health & Human Services, the president says both consumers and the government can save money if drugs were priced along the lines of that of other countries (i.e.,...

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IBB Comments

Write your thoughts about iShares Biotechnology ETF
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Adrian Wechner
Adrian Wechner Jul 21, 2021 2:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wonder if the new wave will give a new push to this sector.
Adam Novak
Adam Novak Jan 14, 2021 12:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Market is too high I sold part of my assets
Bryan Ali
Bryan_Ali Nov 09, 2018 1:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I reentered a short position today with a 2x1 ratio of otm Jan19 puts.. might add more tomorow if the IV continues downward
Sergio Fabrizio
Sergio Fabrizio Nov 09, 2018 1:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
in this program how do I make a short option I keep making call options any info would be awesome
Jai Khushalani
Jai Khushalani Nov 09, 2018 1:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What woudl he the reason for the price to go dowm ?
Jai Khushalani
Jai Khushalani Nov 09, 2018 1:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What would be the reason for the price to go down
John Avenetti
John Avenetti Nov 09, 2018 1:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you lost your ******** the mkt goes up 91% of the time.
Bryan Ali
Bryan_Ali Oct 16, 2018 1:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
reentered puts just now..
Bryan Ali
Bryan_Ali Oct 16, 2018 1:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Out here
Bryan Ali
Bryan_Ali Aug 31, 2018 11:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought some puts earlier today.. 105 October monthlies
Dale Baeten
Dale Baeten Dec 02, 2017 3:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought 107.50 call for 12-8-17  IBB has a lot of near term upside imho
John Doe
John Doe Feb 29, 2016 7:30PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wednesday safe to short
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email